skip links
As a GI focused US healthcare company, collaboration is a core value and a key to our success
  • US

    LINZESS®* available in U.S. through 50/50 collaboration with AbbVie

  • Europe, Canada, Mexico

    CONSTELLA® available in certain European countries through partnership with AbbVie

  • China, Hong Kong & Macau

    LINZESS® approved in Hong Kong, and in China through a collaboration with AstraZeneca

  • Japan

    LINZESS® available in Japan through partnership with Astellas

  • Rest of World

    License to develop and market linaclotide in remaining countries with AbbVie

Ironwood Pharmaceuticals Collaborations world map

At Ironwood, we’re focused on three goals: transforming knowledge into medicines that make a difference for people living with gastrointestinal (GI) diseases, building a team that relentlessly pursues excellence and creating value that will inspire the continued support of our fellow shareholders.

These are not easy tasks, and we recognize the value of collaboration in achieving them. Only by working together can we make medicines that make a difference in people’s lives.

Corporate Partners

Ironwood’s goal is to get our medicines to appropriate patients around the world in the most efficient way possible. We have a track record of establishing, operating and evolving high-performance partnerships globally. With our first internally-developed medicine, linaclotide, we’ve established a network of partners that can help us reach patients.

Collaboration with Physician Professional Organizations and Patient Advocacy Groups

We collaborate with the major GI physician and patient advocacy groups to support research and understanding with the aim to advance medicines and improve patient care.

Partnering Opportunities

As a GI focused, US healthcare company, we are interested in discussing opportunities to collaborate on GI products. We are also seeking partners in territories outside of the US for select current development programs. Please contact us with more details on your area of interest.

Partner with Us